Sniffing out a better mumps shot? new nasal vaccines enter human testing
NCT ID NCT06967181
Summary
This early-stage trial is testing two new mumps vaccines given as a nasal spray. The main goal is to see if they are safe and can trigger an immune response in healthy adults who were vaccinated as children. Up to 60 participants will receive one dose of either vaccine or a placebo spray and be monitored for about a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUMPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center Vaccine Research Center
Cincinnati, Ohio, 45229, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
University Of Rochester Medical Center
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.